Austin pharma company brings in $4 million for Alzheimer's test, painkilling drugs
Pain Therapeutics Inc. has snagged $4 million in federal funding to advance a pair of its innovative treatments.
The Austin-based drugmaker announced Monday it had landed a $2.2 million research-and-development grant from the National Institute on Drug Abuse and a $1.8 million research grant from the National Institutes of Health. The former is for Fenrock, a painkiller patch that is less susceptible to abus e, and the latter is to develop a blood test that can diagnose Alzheimer’s disease.
The…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Will Anderson Source Type: news
More News: Alzheimer's | Funding | Grants | Health Management | National Institutes of Health (NIH) | Pain | Pharmaceuticals | Substance Abuse